← Back to Patent Explorer
US4918165A Expired / Lapsed US ⏱️ 0.0 years remaining

Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction

Assignee: BIOTECHNOLOGY LLC
•
Filing: 1987-07-16
•
Granted: 1990-04-17
•
Expires: 2007-07-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A conjugated cytotoxin is provided for preventing posterior lens capsule opacification (after-cataract) after extracapsular extraction. Preferably, the mitotic inhibitor of lens epithelial cells comprises a conjugate containing methotrexate which is covalently linked to an antibody, such as anticollagen, in approximately a molar ratio of 1:1 to 10:1. The mitotic conjugate may be instilled in the anterior or posterior chamber of the eye, preferably immediately after the lens has been removed, or coated onto an intraocular lens prior to insertion onto the posterior lens capsule. Similar conjugates may be attached to other artificial materials in the body to fight fibroblast proliferation.

Inventors

  • 👤 David B. Soll
  • 👤 Thomsen J. Hansen
  • 👤 Ihab Kamel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 20:23
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/14; A61F2/16; A61F2/0077; A61F2/1613; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/68; A61K47/6801; A61K47/6803; A61L; A61L27/00; A61L27/50; A61L27/54; A61P; A61P27/00; A61P27/02; A61P27/12; A61P35/00; A61P43/00; A61F2/1602; A61F2/1605; A61F2/161; A61F2002/009; A61L2300/00; A61L2300/20; A61L2300/252; A61L2300/256; A61L2300/40; A61L2300/432; A61L2300/45

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 43 words
A mitotic inhibitor for the prevention of posterior lens capsule opacification when instilled into the anterior or posterior chamber of the eye during or after extracapsular extraction comprising: a conjugate of an anticollagen antibody and a cytotoxin to lens epithelial cells and fibroblasts.
Claim 2
Dependent Claim 43 words
A mitotic inhibitor for the prevention of posterior lens capsule opacification when instilled into the anterior or posterior chamber of the eye during or after extracapsular extraction comprising: a conjugate of an anticollagen antibody and a cytotoxin to lens epithelial cells and fibroblasts.
Claim 3
Dependent Claim 15 words
A mitotic inhibitor according to claim 1 wherein said antibody and cytotoxin are covalently linked.
Claim 4
Dependent Claim 12 words
A mitotic inhibitor according to claim 1, wherein said cytotoxin comprises methotrexate.
Claim 5
Dependent Claim 15 words
A mitotic inhibitor according to claim 1, wherein said antibody is specific to lens capsule.
Claim 6
Dependent Claim 15 words
A mitotic inhibitor according to claim 1, wherein said antibody is specific to lens cells.
Claim 7
Dependent Claim 23 words
A mitotic inhibitor according to claim 1, wherein said conjugate comprises methotrexate and anticollagen in a molar ratio of about 1:1 to 10:1.
Claim 8
Dependent Claim 35 words
A method of preventing posterior lens capsule opacification after extracapsular cataract extraction comprising: instilling into the anterior or posterior chamber of the eye during or after the extracapsular extraction the mitotic inhibitor of claim 1.
Claim 9
Dependent Claim 25 words
A method of preventing posterior lens capsule opacification after extracapsular cataract extraction comprising: instilling the mitotic inhibitor of claim 1 immediately following the cataract extraction.
Claim 10
Dependent Claim 24 words
A method of preventing posterior lens capsule opacification after extracapsular cataract extraction comprising: coating of intraocular lenses with the mitotic inhibitor of claim 1.

References Cited (Backward Citations)

US4515794A Cited
US4432751A Cited
US4699784A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-04-16 1993-10-16 1994-04-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-04-16 1997-10-16 1998-04-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-04-16 2001-10-16 2002-04-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag